Search

Your search keyword '"Passalacqua, G."' showing total 75 results

Search Constraints

Start Over You searched for: Author "Passalacqua, G." Remove constraint Author: "Passalacqua, G." Topic immunology Remove constraint Topic: immunology
75 results on '"Passalacqua, G."'

Search Results

1. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

2. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

3. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

4. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

5. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

6. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

7. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity

8. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

9. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

10. Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study

11. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

12. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

13. Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI

14. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

15. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

16. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

17. THE RELEVANCE OF NASAL CYTOLOGY IN THE WORKUP OF HOUSE DUST MITE-INDUCED ALLERGIC RHINITIS

18. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

19. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

20. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA)

21. Cross-sectional comparison of the characteristics of respiratory allergy in immigrants and Italian children

22. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

23. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

24. Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects

25. The Clinical Stage of Allergic Rhinitis is Correlated to Inflammation as Detected by Nasal Cytology

26. The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy

27. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

28. Allergic rhinitis: the nose and beyond.

29. Chronic urticaria and associated coeliac disease in children: A case–control study.

30. Long‐term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial.

31. Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects.

32. Treatment with American Polistes venom was ineffective in an Italian patient allergic to European Polistes.

33. Latex-jujube cross-reactivity: case report and immunological study.

34. Severe asthma: One disease and multiple definitions

35. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

36. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

37. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

38. Management of anaphylaxis due to COVID-19 vaccines in the elderly

39. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

40. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

41. ARIA���EAACI statement on asthma and COVID���19 (June 2, 2020)

42. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

43. Efficacy of Buffered Hypertonic Saline Nasal Irrigation for Nasal Symptoms in Children with Seasonal Allergic Rhinitis: A Randomized Controlled Trial

44. 2019 ARIA Care pathways for allergen immunotherapy

45. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

46. Treatment of allergic rhinitis using mobile technology with real world data: The MASK observational pilot study

47. The work productivity and activity impairment allergic specific (WPAI-AS) questionnaire using mobile technology: The mask study

48. Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms

49. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

50. Nasal budesonide efficacy for nasal nitric oxide and nasal obstruction in rhinitis

Catalog

Books, media, physical & digital resources